Introduction: The New Currency of Healthcare
In today's healthcare landscape, data is the fuel powering nearly every major innovation, from AI-powered diagnostics to predictive population health platforms. As new digital health companies emerge, they often build partnerships centered on the exchange of clinical data to create, refine, and prove the effectiveness of their technologies.
However, these partnerships are rarely a one-way street. Often, a software platform provides immense value to a clinical partner, while the clinical partner provides valuable data back to the platform. Structuring a compliant and successful arrangement requires a sophisticated understanding of this two-way value exchange.
The Old Way: The High Cost of Manual Data
Historically, gathering clinical data was a monumental task. The process of researchers manually reviewing paper charts or painstakingly abstracting information from clunky Electronic Health Records (EHRs) was notoriously slow, labor-intensive, and incredibly expensive.
The cost reflected this inefficiency. The price to collect a single, complete patient record for a traditional clinical study could run into the tens of thousands of dollars, and even manual extraction from an EHR could cost hundreds or thousands per record. This created a significant barrier to innovation, limiting progress to only the most well-funded organizations.
The Digital Shift: Platforms That Create and Consume Data
The modern digital health ecosystem operates on a completely different premise. Innovative software platforms now empower clinical partners, helping them identify at-risk patients, streamline care, and achieve the goals of value-based care arrangements. These platforms don't just consume data; their primary function is to create value for the provider and the patient.
In return for this service, the clinical partner often provides a stream of automated, real-time data back to the platform. This data is essential for the platform to learn, improve its algorithms, and demonstrate its effectiveness. This creates a symbiotic relationship: the platform provides value through its software, and the partner provides value through its data.
The Valuation Challenge: A Two-Sided Equation
This two-way exchange creates a complex valuation challenge. To be compliant with healthcare regulations like the Anti-Kickback Statute, the compensation flowing in both directions must be at Fair Market Value (FMV). You must answer two distinct questions:
- What is the value of the software platform being provided to the clinical partner?
- What is the value of the automated data being provided back to the software platform?
Simply netting these values without a formal, unbundled analysis is a significant compliance risk.
A Defensible Approach: Valuing Both Sides of the Partnership
At Cabra Consulting, we believe the only compliant way to structure these innovative arrangements is to independently value each side of the exchange.
Valuing the Platform's Service: The value a sophisticated software platform provides to a clinical partner can be substantial. A proper valuation often focuses on the economic benefits the platform helps generate. For instance, a platform that enables a provider to succeed in a value-based care contract creates tangible value. The FMV of the software license can be defensibly linked to a portion of these potential shared savings or quality incentive payments, reflecting the value it creates. This demonstrates that technological efficiency leads to high value, not low cost.
Valuing the Data Access: When valuing the raw data being provided back to the platform, the analysis shifts. Here, the principle of cost avoidance becomes relevant. A defensible valuation is based on the cost of the most comparable and efficient alternative method for acquiring that data—which, in the modern era, is automated extraction. The value of this data stream is therefore based on the low per-record cost of modern technology, not the astronomical costs of outdated manual methods.
The final, compliant financial arrangement is the net result of these two independent valuations. This transforms the relationship into a transparent and defensible exchange of services, each priced at its own distinct FMV.
Conclusion: The New Economics of Health Data
The digital transformation of healthcare is creating powerful, symbiotic relationships. In these new ecosystems, value is not a one-way street. A platform's efficiency creates immense value for its clinical partners, and the data from those partners, delivered with equal efficiency, provides value in return.
Structuring these arrangements requires a sophisticated approach that respects this two-way flow. By unbundling the services and valuing each component independently, digital health pioneers can build innovative partnerships that are not only effective but also squarely within the bounds of Fair Market Value.
If your digital health organization is building partnerships that involve a two-way exchange of value, our experts at Cabra Consulting can help. Contact us today to ensure your arrangements are built on a solid and defensible Fair Market Value foundation.